Pharma Focus Asia
KP - Sustainable Packaging Solutions

Janssen Invests in R &D Facility Expansion in San Francisco


Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) plans to invest in a new R&D facility and expand its presence in the San Francisco Bay Area.


The investment will support the leasing and construction of the state-of-the-art R&D facility in the global innovation center of South San Francisco.

The expansion will allow the company to focus on main interdisciplinary capabilities, such as data science and biology to fuel a step-change in how it creates medicine.

Janssen's researchers at the new facility will be put to work on infectious and retinal diseases, data science and emerging modalities within discovery, product development, and supply.    

Upon completion of construction, the expanded facility is projected to more than double Janssen's presence in San Francisco and is expected to be fully operational in 2022.

The investment will allow Janssen to continue ‘world class discovery’ and will also increase its capabilities to merge with other companies on various research and discovery projects.
However, the investment amount has been undisclosed.


NameJanssen Pharmaceutical Companies of Johnson & Johnson
LocationSan Francisco
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024CPHI Chine || PMEC China 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024CPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?